AU4825993A - New compounds for use in the treatment of cancer - Google Patents

New compounds for use in the treatment of cancer

Info

Publication number
AU4825993A
AU4825993A AU48259/93A AU4825993A AU4825993A AU 4825993 A AU4825993 A AU 4825993A AU 48259/93 A AU48259/93 A AU 48259/93A AU 4825993 A AU4825993 A AU 4825993A AU 4825993 A AU4825993 A AU 4825993A
Authority
AU
Australia
Prior art keywords
cancer
treatment
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48259/93A
Inventor
Helen Mary Coley
Michael Jarman
Ian Robert Judson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Publication of AU4825993A publication Critical patent/AU4825993A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU48259/93A 1992-09-18 1993-09-17 New compounds for use in the treatment of cancer Abandoned AU4825993A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9219776 1992-09-18
GB929219776A GB9219776D0 (en) 1992-09-18 1992-09-18 New compounds for use in the treatment of cancer
PCT/GB1993/001967 WO1994006781A1 (en) 1992-09-18 1993-09-17 New compounds for use in the treatment of cancer

Publications (1)

Publication Number Publication Date
AU4825993A true AU4825993A (en) 1994-04-12

Family

ID=10722134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48259/93A Abandoned AU4825993A (en) 1992-09-18 1993-09-17 New compounds for use in the treatment of cancer

Country Status (3)

Country Link
AU (1) AU4825993A (en)
GB (1) GB9219776D0 (en)
WO (1) WO1994006781A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021191A1 (en) * 1995-05-16 1998-05-22 Nissan Chemical Industries, Ltd. Cyanoethylmelamine derivatives and process for producing the same
US6262053B1 (en) 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
WO2009157628A1 (en) * 2008-06-23 2009-12-30 Industry-Academic Cooperation Foundation, Yonsei University Pharmaceutical composition for treating or preventing cancer comprising triazine compound as an active ingredient
CN113288899B (en) * 2021-05-17 2022-10-11 浙江工业大学 Application of heterocyclic thiol compound in preparation of antitumor drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106170D0 (en) * 1991-03-22 1991-05-08 Jarman Michael New compounds for use in the treatment of cancer

Also Published As

Publication number Publication date
GB9219776D0 (en) 1992-10-28
WO1994006781A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
ZA957483B (en) Compounds and methods for the treatment of cancer
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
AU3969793A (en) Use of nitric oxide/nucleophile complexes for the treatment of cancer
GB9305470D0 (en) New substituted azetidinones useful in the treatment of cancer
AU5590696A (en) Use of quinones in the treatment of cancer or AIDS
IL101410A0 (en) Formulation for the treatment of cancer
AU2821295A (en) Compositions and methods for the treatment of tumors
AU1480497A (en) Cancer treatment
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
AU3187595A (en) Compounds for the treatment of restenosis
AU5340594A (en) Skin treatment
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
ZA922073B (en) New compounds for use in the treatment of cancer
AU7770991A (en) Method and composition for the treatment of cancer
AU4825993A (en) New compounds for use in the treatment of cancer
AU5371694A (en) Use of the tarchonanthus camphoratus
GB9308166D0 (en) Cancer therapy
AU3902393A (en) Water treatment
GB9218711D0 (en) Skin cancer treatment
AU3641993A (en) Treatment chamber
GB2312375B (en) Agents for treatment of cancer
AU5165993A (en) Pp14-based therapy
GB9305467D0 (en) Substituted cephalosporin sulfones useful in the treatment of cancer
AU648084B2 (en) Agent for therapy